Therefore, tumor biomarkers have already been used for specific cancer identification, including carcinoembryonic antigen (CEA) for colorectal cancer [24], α-fetoprotein (AFP) for liver cancer [16] and prostate specific antigen (PSA) [52]. Here, CEACAM5 is linked to colorectal cancer.